Prism Biolab Co (TSE:206A) Shares Outstanding (Basic Average): 36.9 Mil (As of Mar. 2026)


TSE:206A Prism Biolab Co Ltd TSE:206A
11 GF Score
Price 円127.00
! 2 Warning Signs
View Full Analysis

What is Prism Biolab Co Shares Outstanding (Basic Average)?

Prism Biolab Co TSE:206A -5.93% 11 Shares Outstanding (Basic Average) is 36.9 Mil as of Mar. 2026. GuruFocus rates TSE:206A with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Prism Biolab Co's average basic shares outstanding for the quarter that ended in Mar. 2026 was 36.9 Mil.


Prism Biolab Co  (TSE:206A) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Prism Biolab Co Shares Outstanding (Basic Average) Related Terms


Prism Biolab Co Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Prism Biolab Co's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Biolab Co Shares Outstanding (Basic Average) Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24 Sep25
Shares Outstanding (Basic Average)
29.81 29.81 31.30 36.53

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial 29.04 33.57 36.34 36.73 36.92
TSE:206A
11GF Score
Prism Biolab Co Ltd TSE:206A
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prism Biolab Co Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 36.9 Mil mean?
Prism Biolab Co (TSE:206A) has a Shares Outstanding (Basic Average) of 36.9 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Prism Biolab Co and its competitors.
Is Prism Biolab Co's Shares Outstanding (Basic Average) too high?
Prism Biolab Co's current Shares Outstanding (Basic Average) is 36.9 Mil. Overall, Prism Biolab Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Prism Biolab Co's Shares Outstanding (Basic Average) compare to VRTX and REGN?
Prism Biolab Co's Shares Outstanding (Basic Average) of 36.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Biotechnology company?
A good Shares Outstanding (Basic Average) depends on the Biotechnology industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Prism Biolab Co and its competitors. Prism Biolab Co's current Shares Outstanding (Basic Average) is 36.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Biolab Co stock overvalued right now?
Prism Biolab Co (TSE:206A) has a current Shares Outstanding (Basic Average) of 36.9 Mil. The current Shares Outstanding (Basic Average) is 36.9 Mil. Prism Biolab Co's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Prism Biolab Co (TSE:206A), the current Shares Outstanding (Basic Average) is 36.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prism Biolab Co Business Description

Address 26-1, Muraoka-Higashi 2-chome, Kanagawa Prefecture, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.
11GF Score

Get the complete analysis for TSE:206A

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円127.00
Price